The Price Elasticity of Specialty Drug Use: Evidence from Cancer Patients in Medicare Part D

Business & Economics

• Drug Use 85%
• Medicare 80%
• Cancer 71%
• Price Elasticity 61%
• Drugs 50%
• Patient Cost-Sharing 8%
• Price Effects 5%
• Insurer 4%
• Low Income 4%
• Subsidies 4%
• Costs 1%

Social Sciences

• price elasticity 100%
• cancer 55%
• drug use 53%
• drug 41%
• evidence 25%
• cost sharing 13%
• demand 6%
• subsidy 4%
• low income 3%
• coverage 3%
• costs 2%

Medicine & Life Sciences

• Medicare Part D 94%
• Elasticity 68%
• Pharmaceutical Preparations 25%
• Neoplasms 19%
• Cost Sharing 14%
• Elderly 6%
• Formularies 6%
• Off-Label Use 6%
• Insurance Carriers 5%
• Income 3%
• Costs and Cost Analysis 2%
• Therapeutics 0%